New findings on radiation plus adjuvant chemotherapy in patients with intermediate-risk cervical cancer seem to spell the end for the dual therapy in this group. Results from a phase 3 clinical trial ...

Please provide your email address to receive an email when new articles are posted on . The addition of chemotherapy to radiotherapy did not improve OS in intermediate-risk cervical cancer. Patients ...

Please provide your email address to receive an email when new articles are posted on . Chemoradiation and radiation alone conferred comparable RFS and OS benefits. Grade 3/grade 4 adverse events ...

In this study, we sought to identify a criterion for the intermediate-risk grouping of patients with cervical cancer who exhibit any intermediate-risk factor after radical hysterectomy. Four factors ...